SCHEMBL7990042

SCHEMBL7990042

COCCCC/C=C/c1cccc(C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 1/20 0.47
NPC1 O15118 1/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
PTGS1 P23219 2/20 0.41
PTGS2 P35354 2/20 0.41
ALOX5 P09917 1/20 0.41
TP53 P04637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
FBP1 P09467 1/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP1A2 P05177 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
BACE1 P56817 1/20 0.38
IDO1 P14902 2/20 0.38
LTB4R Q15722 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8000066 0.98 RELA (0.46) RELANPC1CASP3SENP8SENP7
SCHEMBL7998452 0.95 RELA (0.49) RELANPC1CASP3SENP8SENP7
SCHEMBL7989611 0.89 RELA (0.51) RELANPC1CASP3SENP8SENP7
SCHEMBL13845988 0.83 APP (0.49) MEN1KMT2ACYP1A2HPGDCYP2C19
SCHEMBL7998443 0.82 RELA (0.43) RELANPC1CASP3SENP8SENP7
SCHEMBL7998446 0.82 RELA (0.43) RELANPC1CASP3SENP8SENP7
SCHEMBL12680909 0.82 RELA (0.40) RELANPC1CASP3SENP8SENP7
SCHEMBL13846023 0.82 APP (0.48) MEN1KMT2ACYP1A2HPGDCYP2C19
SCHEMBL106151 0.80 PTGS1 (0.46) RELANPC1CASP3SENP8SENP7
SCHEMBL27851001 0.80 PTGS1 (0.46) RELANPC1CASP3SENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117594-A1 FLUORINATED MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-09-24 WO disclosed
WO-2009079353-A1 TRIAZOLE-CONTAINING MACROCYCLIC HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-06-25 WO disclosed